Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bergen Brunswig recapitalization

Executive Summary

A suit challenging certain aspects of the proposed recapitalization plan was filed in the Superior Court of the State of California for Orange County. The suit brought by Aline Halye of New Jersey and other shareowners is a derivative and class action complaint seeking monetary and equitable relief. Bergen Brunswig said that the allegations "appear to be without merit" and "a vigorous defense is planned. "The plan was proposed on Aug. 10 ("The Pink Sheet" Aug. 15, T&G-11).

Latest Headlines
See All
UsernamePublicRestriction

Register

PS014542

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel